Top Markets
Coin of the day
OnKure Therapeutics, Inc. OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.

OKUR
Rang in aandelen #19617
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a... OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
Aandeelprijs
$3.86
Laatst gesynchroniseerd: 2026-08-25
Marktkapitalisatie
$156.32M
Verandering (1 dag)
-0.77%
Verandering (1 jaar)
40.36%
Land
US
Handel OnKure Therapeutics, Inc. (OKUR)

Categorie

Dividendrendementgeschiedenis voor OnKure Therapeutics, Inc. (OKUR)
Het dividendrendement (TTM) van OnKure Therapeutics, Inc. (aandelsymbool: OKUR) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van OnKure Therapeutics, Inc. (OKUR) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH